Microlife BP A7 Touch BT Manual Del Usuario página 3

Microlife BP A7 Touch BT
1 Enter
2 Display
3 Lock Switch
4 Cuff Socket
5 AFIB/MAM Switch
6 + «Forward» Button
7 - «Backward» Button
8 USB Port
9 Mains Adapter Socket
AT Battery Compartment
AK Cuff
AL Cuff Connector
AM Cuff Tube
Display
AN START/STOP Button
AO M-button (memory)
AP Systolic Value
AQ Diastolic Value
AR Pulse Rate
AS Battery Display
BT Cuff Check Indicator
BK Arm Movement Indicator
BL Atrial Fibrillation Indicator (AFIB)
BM User Indicator
BN AFIB/MAM Mode
BO AFIB/MAM Interval Time
BP Traffic Light Indicator
BQ Date/Time
BR Pulse Indicator
BS Active Bluetooth ®
Read the instructions carefully before using this device.
Type BF applied part
Keep dry
BP A7 Touch BT
Intended use:
This oscillometric blood pressure monitor is intended for measuring
non-invasive blood pressure in people aged 12 years or older.
It is clinically validated in patients with hypertension, hypotension,
diabetes, pregnancy, pre-eclampsia, atherosclerosis, end-stage
renal disease, obesity and the elderly.
The device can detect an irregular pulse suggestive of Atrial Fibril-
lation (AF). Please note that the device is not intended to diagnose
AF. A diagnosis of AF can only be confirmed by ECG. The patient
is advised to see a physician.
Dear Customer,
This device was developed in collaboration with physicians and
clinical tests carried out prove its measurement accuracy to be of
a very high standard.*
Microlife AFIBsens is the world's leading digital blood pressure
measurement technology for the detection of atrial fibrillation (AF)
and arterial hypertension. These are the two top risk factors of
getting a stroke or heart disease. It is important to detect AF and
hypertension at an early stage, even though you may not experi-
ence any symptoms. AF screening in general and thus also with
the Microlife AFIB algorithm, is recommended for people of 65
years and older. The AFIB algorithm indicates that atrial fibrillation
may be present. For this reason, it is recommended that you visit
your doctor when the device gives an AFIB signal during your
blood pressure measurement. The AFIB algorithm of Microlife has
been clinically investigated by several prominent clinical investiga-
tors and showed that the device detects patients with AFIB at a 1,2
certainty of 97-100%.
If you have any questions, problems or want to order spare parts
please contact your local Microlife-Customer Service. Your dealer
or pharmacy will be able to give you the address of the Microlife
dealer in your country. Alternatively, visit the internet at
www.microlife.com where you will find a wealth of invaluable infor-
mation on our products.
Stay healthy – Microlife AG!
* This device uses the same measuring technology as the award
winning «BP 3BTO-A» model tested according to the British and
Irish Hypertension Society (BIHS) protocol.
1
Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D,
Hobbs FR et al.: Triage tests for identifying atrial fibrillation in
primary care: a diagnostic accuracy study comparing single-lead
ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
EN
EN
1